Full Text
PGI5 COST-EFFECTIVENESS OF NATALIZUMAB IN CROHNS DISEASE PATIENTS WHO HAVE FAILED ANTI-TNF ALPHA THERAPY

Abstract

Authors

S Panjabi T Niecko SL Hass L Lacey MD Spencer

Back to Volume 11, Issue 3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×